News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gilead Sciences, Inc. (GILD) Successfully Completes Tender Offer for Shares of CV Therapeutics, Inc. (CVTX) With Over 88 Percent of Shares Tendered


4/15/2009 9:15:12 AM

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) announced today the successful completion of its cash tender offer for all of the outstanding shares of common stock of CV Therapeutics, Inc. (Nasdaq:CVTX). The offer expired as scheduled at one minute following 11:59 p.m., New York City time (midnight), on April 14, 2009.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES